PMC:7102662 / 2220-2431 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T23","span":{"begin":6,"end":14},"obj":"Disease"}],"attributes":[{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"us-2 (SARS-CoV-2), has presented an unprecedented challenge for the healthcare community across the world. High infectivity, ability to get transmitted even during asymptomatic phase and relatively low virulence"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T6","span":{"begin":19,"end":22},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"us-2 (SARS-CoV-2), has presented an unprecedented challenge for the healthcare community across the world. High infectivity, ability to get transmitted even during asymptomatic phase and relatively low virulence"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":202,"end":211},"obj":"http://purl.obolibrary.org/obo/GO_0016032"},{"id":"T3","span":{"begin":202,"end":211},"obj":"http://purl.obolibrary.org/obo/GO_0009405"}],"text":"us-2 (SARS-CoV-2), has presented an unprecedented challenge for the healthcare community across the world. High infectivity, ability to get transmitted even during asymptomatic phase and relatively low virulence"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T40","span":{"begin":6,"end":16},"obj":"SP_7"}],"text":"us-2 (SARS-CoV-2), has presented an unprecedented challenge for the healthcare community across the world. High infectivity, ability to get transmitted even during asymptomatic phase and relatively low virulence"}

{"project":"LitCovid-PubTator","denotations":[{"id":"123","span":{"begin":6,"end":16},"obj":"Species"}],"attributes":[{"id":"A123","pred":"tao:has_database_id","subj":"123","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"us-2 (SARS-CoV-2), has presented an unprecedented challenge for the healthcare community across the world. High infectivity, ability to get transmitted even during asymptomatic phase and relatively low virulence"}